Alkermes (ALKS) Reports Q3 Loss of $0.11, Raises FY12 Guidance
Alkermes (NASDAQ: ALKS) reported Q3 EPS of ($0.11), $0.10 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $125.6 million versus the consensus estimate of $113.94 million.
Alkermes sees FY2012 EPS of $-0.71-$-0.61, versus prior guidance of $-0.89-$-0.78 and the consensus of $-0.74. Alkermes sees FY2012 revenue of $370-$400 million, versus prior guidance of $350-$380 million and the consensus of $369.91 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Alkermes sees FY2012 EPS of $-0.71-$-0.61, versus prior guidance of $-0.89-$-0.78 and the consensus of $-0.74. Alkermes sees FY2012 revenue of $370-$400 million, versus prior guidance of $350-$380 million and the consensus of $369.91 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.